Abuse-deterrent pharmaceutical compositions

US10702607B2 · kind B2 · utility

Assignee

• G.L. PHARMA GMBH · AT

Inventors

• Georg GUEBITZ · Graz, AT
• Katrin Greimel · Graz, AT
• Martin Brandauer · Wien, AT
• Daniela Huber · Hollabrunn, AT
• Klaus Bleymaier · Wien, AT
• Wolfgang Kroutil · Graz, AT
• Doris Lechner · Graz, AT
• Christof Wachter · Lannach, AT
• Harald Wagner · Graz, AT
• Heimo Winkler · Graz, AT

Key dates

• Filing date: Feb 28, 2017
• Grant date: Jul 7, 2020
• Expiry date: Feb 28, 2037

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P25/36
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Disclosed are pharmaceutical compositions comprising oxycodone and an oxycodone-processing enzyme, wherein oxycodone is contained in the pharmaceutical composition in a storage stable, enzyme-reactive state and under conditions wherein no enzymatic activity acts on oxycodone.